La vendita allo scoperto per Moelis dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Moelis. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Moelis (NYSE:MC) Azioni, Report sulle vendite allo scoperto

Moelis

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Moelis & Co

Merit Circle - United States Dollar

Mountain & Co I Acquisition Corp

MONTEREY CAP ACQUISITION CORP CL A

MONTEREY CAP ACQUISITION CORP RT

MONTEREY CAP ACQUISITION CORP UNIT 1 CL A & 1 RT & 1 WT

MONTEREY CAP ACQUISITION CORP WT EXP

Mountain Crest Acquisition Corp IV

MOUNTAIN CREST ACQUISITION CORP IV RT

Mountain Crest Acquisition Corp IV Units (1 Ordinary Shares& 1 Rights)

Mountain Crest Acquisition Corp. V - Common Stock

Mountain Crest Acquisition Corp V

Mountain Crest Acquisition Corp. V - Right

Mountain Crest Acquisition Corp. V - Unit

MCAP Inc

Mercari Inc

Mcashchain

MacroAsia Corp

Metropolitan Bank Holding Corp. Common Stock

Metropolitan Bank Holding Corp

MCDEX Token

Macatawa Bank Corp. Com

MOUNTAIN COMM BANCORP INC by Mountain Commerce Bancorp Inc.

Mountain Commerce Bancorp Inc

MADISON COUNTY FINCL INC by Madison County Financial, Inc.

Madison County Financial Inc

MERHAV-CERMC & BLDG MTRLS by MERHAV-CERAMIC & BUILDING MATERIALS CENTER LTD.

Hamat Group Ltd

MICHIGAN COMMUTY BNCRP by Michigan Community Bancorp Ltd.

McBride PLC

MetroCity Bankshares, Inc. - Common Stock

MetroCity Bankshares Inc

MCCHIP RESOURCES INC by McChip Resources, Inc.

McChip Resources Inc

Mestek Inc

MCCOY GLOBAL INC ORD by McCoy Global, Inc.

McCoy Global Inc

MCX Technologies Corp

McDonald's Corp

KMA Holding Inc

McDermott International Ltd Warrants - Class B (30/06/2027)

McDermott International Ltd

MCDERMOTT INT LTD by McDermott International LTD.

MACDONALD MINES EXPL LTD by MacDonald Mines Exploration Ltd.

MacDonald Mines Exploration Ltd

JPMorgan Fundamental Data Science Mid Core ETF

McDermott International Ltd Warrants - Class A (30/06/2027)

MCDONALD'S ORD

MILLENNIUM CELL INC by Millennium Cell, Inc.

Millennium Cell Inc

MONARCH CEMENT CO by Monarch Cement Co. (The)

Monarch Cement Co

MULTICELL TECHS INC by MultiCell Technologies, Inc.

MultiCell Technologies Inc

MCF Energy Ltd

MasterCraft Boat Holdings, Inc. - Common Stock

MasterCraft Boat Holdings Inc

Matthews International Funds Matthews China Active ETF

MATCHAAH HOLDING INC by Matchaah Holdings, Inc.

Matchaah Holdings Inc

MECHANICS BK RICHMOND CAL by Mechanics Bank of Richmond (CA)

Mechanics Bank

MACMAHON HOLDINGS LTD ORD by MacMahon Holdings Ltd.

Macmahon Holdings Ltd

iShares MSCI China ETF

MARUICHI STEEL TUBE LTD by Maruichi Steel Tube Ltd.

Maruichi Steel Tube Ltd

ISHARES MSCI CHINA ETF

MCHENRY BANCORP INC by McHenry Bancorp Inc

McHenry Bancorp Inc

IVZ MSCI CHINA ALL SHR CON UCITS ETF

MULTICHOICE GROUP SP/ADR by MultiChoice Group Limited

MultiChoice Group Ltd

Microchip Technology Incorporated - Common Stock

Microchip Technology Inc

MICROCHIP TECHNOLOGY ORD

Matthews China Discovery Active ETF

M CASH INTEGRASI TBK ORD by M Cash Integrasi Tbk PT

MAUCH CHUNK TR FINCL CORP by Mauch Chunk Trust Financial Corp.

Mauch Chunk Trust Financial Corp

IVZ MSCI CHNA TCH AL SH UCTS ETF ACC

MGM CHINA HOLDINGS ORD by MGM China Holdings, Ltd.

MGM China Holdings Ltd

MGM CHINA HLDGS UNSP/ADR by MGM China Holdings, Ltd.

Marchex Inc

Barings Corporate Investors

MERCIA ASSET MGMT PLC by Mercia Asset Mgmt Plc

Mercia Asset Management PLC

MULTICORP INTL INC by Multicorp International, Inc.

MultiCorp International Inc

MACAU CAP INVSTS INC NEW by Macau Capital Investments, Inc.

Macau Capital Investments Inc

MCI Onehealth Technologies Inc Ordinary Shares - Class A (Sub Voting)

MCJ Co Ltd

McKesson Corp

MALLINCKRODT PB LTD CO by Mallinckrodt plc.

Mallinckrodt PLC

Jade Leader Corp

MORSES CLUB PLC by MORSES CLUB PLC

MCLOUD TECHNOLOGIES INC by MCLOUD TECHNOLOGIES CORP.

mCloud Technologies Corp

Medicale Corp

MCLOUD TECHS CORP 9 PFD A by MCLOUD TECHNOLOGIES CORP.

mCloud Technologies Corp Warrants (29/11/2026)

Madison Covered Call & Equity Strategy Fund Common Stock

Madison Covrd Call & Eqt Strtg Fd

Macnica Holdings Inc

MUCINNO HOLDING INC by Mucinno Holding, Inc.

Mucinno Holding Inc

MILLENNIUM & CPTHRNE HTLS by Millennium & Copthorne Hotels New Zealand Ltd.

Millennium & Copthorne Hotels New Zealand Ltd

Moodys Corp

MCO - United States Dollar

Moss Carbon Credit - United States Dollar

MARIJUANA CO OF AMER INC by Marijuana Company of America, Inc.

Marijuana Company of America Inc

MULTICHOICE GROUP LIMITED by MultiChoice Group Limited

MICROMOBILITY.COM INC A by Micromobility.com Inc.

Micromobility com Inc

Micromobility com Inc Warrants (28/10/2024)

MT CARMEL PUBLIC UTIL CO by Mt. Carmel Public Utility Co.

Mount Carmel Public Utility Co

Midland Capital Holdings Corp Com

MACQUARIE GRP LTD by Macquarie Group, Ltd.

Macquarie Group Ltd

MFS Charter Income Trust

MCRAE INDUS INC A by McRae Industries, Inc.

McRae Industries Inc

MCRAE INDUS INC B by McRae Industries, Inc.

Seres Therapeutics Inc

MICROPORT CRDFLW MD U/ADR by MICROPORT CARDIOFLOW MEDTECH CORP.

MicroPort CardioFlow Medtech Corp

<p>In the latest quarter, 4 analysts provided ratings for Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Moelis, presenting an average target of $65.75, a high estimate of $70.00, and a low estimate of $60.00. This upward trend is evident, with the current average reflecting a 8.37% increase from the previous average price target of $60.67.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1729792840_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>A comprehensive examination of how financial experts perceive Moelis is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$66.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$60.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$67.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Moelis. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Moelis compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Moelis's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Moelis's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Moelis analyst ratings.</strong></a></p>
<h2>All You Need to Know About Moelis</h2>
<p>Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.</p>
<h3>Moelis's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Moelis displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>47.1%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Moelis's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>4.97%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Moelis's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>3.65%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Moelis's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.28%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.59</strong>.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

What Analysts Are Saying About Moelis Stock

<p>Morgan Stanley  analyst Ryan Kenny   maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Underweight and lowers the price target from $67 to $66.</p>


News

Price Target

Morgan Stanley Maintains Underweight on Moelis, Lowers Price Target to $66

<p>Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.21 by 4.76 percent.  The company reported quarterly sales of $280.730 million which beat the analyst consensus estimate of $273.187 million by 2.76 percent.  This is a 1.10 percent increase over sales of $277.665 million the same period last year.</p>


Earnings

Earnings Beats

Moelis Q3 2024 Adj. EPS $0.22 Beats $0.21 Estimate, Sales $280.730M Beat $273.187M Estimate

<p><strong>Moelis</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-10-23. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Moelis will report an <strong>earnings per share</strong> (EPS) of $0.24. </p>
<p>Moelis bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.08 in the last quarter, leading to a 6.42% increase in the share price on the following day.</p>
<p>Here's a look at Moelis's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.10</td>
<td>0.13</td>
<td>-0.11</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.18</td>
<td>0.22</td>
<td>-0.06</td>
<td>-0.15</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>6.0%</td>
<td>-7.000000000000001%</td>
<td>1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1729620196_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Moelis were trading at $70.64 as of October 21. Over the last 52-week period, shares are up 78.93%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MC/earnings"><strong>To track all earnings releases for Moelis visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


An Overview of Moelis's Earnings

<p>Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) in the last three months.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $59.86, a high estimate of $70.00, and a low estimate of $50.00. This upward trend is evident, with the current average reflecting a 10.85% increase from the previous average price target of $54.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1728406813_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>The standing of Moelis among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$60.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$67.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>-</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$51.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$60.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$61.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$54.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Moelis. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Moelis compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Moelis's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Moelis's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Moelis analyst ratings.</strong></a></p>
<h2>About Moelis</h2>
<p>Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.</p>
<h3>Financial Insights: Moelis</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Moelis's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>47.1%</strong> as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Moelis's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>4.97%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Moelis's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>3.65%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Moelis's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.28%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.59</strong>, Moelis adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


In-Depth Examination Of 7 Analyst Recommendations For Moelis

<p>UBS  analyst Brennan Hawken   maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Sell and raises the price target from $54 to $60.</p>


UBS Maintains Sell on Moelis, Raises Price Target to $60

<p>Morgan Stanley  analyst Ryan Kenny   maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Underweight and raises the price target from $61 to $67.</p>


Morgan Stanley Maintains Underweight on Moelis, Raises Price Target to $67

<p>6 analysts have expressed a variety of opinions on Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $57.0, along with a high estimate of $70.00 and a low estimate of $50.00. This upward trend is apparent, with the current average reflecting a 11.33% increase from the previous average price target of $51.20.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726174875_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Moelis by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>-</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$51.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$60.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$61.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$50.00</td>
<td>$47.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Moelis. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Moelis compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Moelis's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Moelis's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Moelis analyst ratings.</strong></a></p>
<h2>Discovering Moelis: A Closer Look</h2>
<p>Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.</p>
<h3>Moelis's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> Moelis's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately <strong>47.1%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>4.97%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>3.65%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Moelis's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.28%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.59</strong>, Moelis adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Scoreboard: 6 Ratings For Moelis

<p>Wells Fargo  analyst Michael Brown   initiates coverage on Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Equal-Weight rating and announces Price Target of $70.</p>


Initiation

Wells Fargo Initiates Coverage On Moelis with Equal-Weight Rating, Announces Price Target of $70

<p>Revealing a significant insider sell on July 29, <strong>Joseph Simon</strong>, Chief Financial Officer at <strong>Moelis</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>), as per the latest SEC filing.</p>
<p><strong>What Happened:</strong> Simon's decision to sell 6,723 shares of <strong>Moelis</strong> was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001596967/000095017024087449//Archives/edgar/data/1596967/000095017024087449/0000950170-24-087449-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The total value of the sale is $430,272.</p>
<p>Monitoring the market, <strong>Moelis</strong>'s shares down by 0.0% at $67.39 during Tuesday's morning.</p>
<h3>Delving into Moelis's Background</h3>
<p>Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.</p>
<h3>Understanding the Numbers: Moelis's Finances</h3>
<p><strong>Revenue Growth:</strong> Moelis displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately <strong>47.1%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Evaluating Earnings Performance:</strong></p>
<ul>
<li>
<p><strong>Gross Margin:</strong> With a low gross margin of <strong>25.21%</strong>, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.</p>
</li>
<li>
<p><strong>Earnings per Share (EPS):</strong> Moelis's EPS reflects a decline, falling below the industry average with a current EPS of <strong>0.18</strong>.</p>
</li>
</ul>
<p><strong>Debt Management:</strong> Moelis's debt-to-equity ratio is below the industry average. With a ratio of <b>0.59</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><strong>Navigating Market Valuation:</strong></p>
<ul>
<li>
<p><strong>Price to Earnings (P/E) Ratio:</strong> With a higher-than-average P/E ratio of <strong>449.27</strong>, Moelis's stock is perceived as being overvalued in the market.</p>
</li>
<li>
<p><strong>Price to Sales (P/S) Ratio:</strong> With a higher-than-average P/S ratio of <strong>5.03</strong>, Moelis's stock is perceived as being overvalued in the market, particularly in relation to sales performance.</p>
</li>
<li>
<p><strong>EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization):</strong> Boasting an EV/EBITDA ratio of <strong>855.43</strong>, Moelis demonstrates a robust market valuation, outperforming industry benchmarks.</p>
</li>
</ul>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><a href="https://www.schwab.com/brokerage?aff=XEC"><em>Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</em></a></p>
<h3>Why Pay Attention to Insider Transactions</h3>
<p>Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.</p>
<p>Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.</p>
<p>Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.</p>
<p>But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.</p>
<h3>The Insider's Guide to Important Transaction Codes</h3>
<p>For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A <strong>P</strong> in Box 3 denotes a purchase, while <strong>S</strong> signifies a sale. Transaction code <strong>C</strong> signals the conversion of an option, and transaction code <strong>A</strong> denotes a grant, award, or other acquisition of securities from the company.</p>
<p><a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001596967"><strong>Check Out The Full List Of Moelis's Insider Trades.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insider Trades

Trading Ideas

Joseph Simon Takes Money Off The Table, Sells $430K In Moelis Stock

<p>JP Morgan  analyst Kenneth Worthington   maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Neutral and raises the price target from $50 to $51.</p>


JP Morgan Maintains Neutral on Moelis, Raises Price Target to $51

<p>Keefe, Bruyette &amp; Woods  analyst Aidan Hall   reiterates Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Market Perform and raises the price target from $54 to $60.</p>


Reiteration

Keefe, Bruyette & Woods Reiterates Market Perform on Moelis, Raises Price Target to $60

<p>Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.11 by 63.64 percent. This is a 550 percent increase over losses of $(0.04) per share from the same period last year.  The company reported quarterly sales of $264.586 million which beat the analyst consensus estimate of $227.373 million by 16.37 percent.  This is a 45.18 percent increase over sales of $182.243 million the same period last year.</p>


Moelis Q2 2024 Adj EPS $0.18 Beats $0.11 Estimate, Sales $264.586M Beat $227.373M Estimate

<p>In the last three months, 5 analysts have published ratings on Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Moelis and provided 12-month price targets. The average target is $52.4, accompanied by a high estimate of $61.00 and a low estimate of $47.00. Witnessing a positive shift, the current average has risen by 2.75% from the previous average price target of $51.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1721757703_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>A clear picture of Moelis's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$61.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$50.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$47.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$54.00</td>
<td>$58.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Moelis. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Moelis compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Moelis's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>To gain a panoramic view of Moelis's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MC/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Moelis analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Moelis</h2>
<p>Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.</p>
<h3>Moelis: Delving into Financials</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Moelis displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately <strong>15.79%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>7.62%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>4.62%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Moelis's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.51%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Moelis's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.58</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Evaluating Moelis: Insights From 5 Financial Analysts

<p>Morgan Stanley  analyst Ryan Kenny   maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Underweight and raises the price target from $51 to $61.</p>


Morgan Stanley Maintains Underweight on Moelis, Raises Price Target to $61

<p>JP Morgan  analyst Kenneth Worthington   maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Neutral and lowers the price target from $54 to $50.</p>


JP Morgan Maintains Neutral on Moelis, Lowers Price Target to $50

<p>UBS  analyst Brennan Hawken   maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Sell and raises the price target from $47 to $50.</p>


UBS Maintains Sell on Moelis, Raises Price Target to $50

WIIM

Shares of investment banks are trading higher. The financial sector may be reacting to Thursday's presidential debate.

Moelis Announces Resignation Of Jonathan Kaye Following Punching Incident

Moelis Reportedly Reviewing Options For 777 Partners' Football Assets

Madison Mid Cap Fund Q3 2024 Investment Strategy Letter

Moelis Non-GAAP EPS of $0.22 beats by $0.03, revenue of $273.76M in-line

Moelis declares $0.60 dividend

Moelis ( ($MC) ) just unveiled an update. Moelis & Company reported a slight increase in third-quarter adjusted revenues to $280.7 million, amid a ...

Moelis Reports Revenue Growth and Strong Financial Position

Moelis & Company (MC) Q3 2024 Earnings Call Transcript

JMP Securities analyst Devin Ryan maintained a Hold rating on Moelis (MC – Research Report) today. The company's shares closed yesterday at $68.24....

Moelis (MC) Receives a Rating Update from a Top Analyst

Evercore: Markets Might Not Have Liked Lack Of Sponsor Business

Artisan Mid Cap Value Fund Q3 2024 Commentary

In a report released today, James Mitchell from Seaport Global maintained a Hold rating on Moelis (MC – Research Report). The company's shares clos...

Comments

Moelis

Vendite allo scoperto

Moelis (NYSE:MC) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO